PTEN mutations in eight Spanish families and one Brazilian family with Cowden syndrome

被引:17
作者
Bussaglia, E
Pujol, RM
Gil, MJ
Martí, RM
Tuneu, A
Febrer, MI
Garcia-Patos, V
Ruiz, EM
Barnadas, M
Alegre, M
Serrano, S
Matias-Guiu, X
机构
[1] Hosp Santa Creu & Sant Pau, Dept Pathol, Barcelona 08025, Spain
[2] Hosp Santa Creu & Sant Pau, Dept Dermatol, Barcelona 08025, Spain
[3] Hosp del Mar, Dept Dermatol, Barcelona, Spain
[4] Univ Lleida, Dept Dermatol, Lleida, Spain
[5] Hosp Virgen Aranzazu, Dept Dermatol, San Sebastian, Spain
[6] Gen Hosp, Dept Dermatol, Valencia, Spain
[7] Hosp Gen Valle Hebron, Dept Dermatol, Barcelona, Spain
[8] Hosp Clin Univ, Dept Dermatol, Valencia, Spain
[9] Hosp Gen Elda, Dept Internal Med, Elda, Spain
关键词
Cowden syndrome; germline mutations; PTEN;
D O I
10.1046/j.1523-1747.2002.01728.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Cowden syndrome is an autosomal dominant genodermatosis, characterized by the presence of multiple hamartomas in the skin, breast, thyroid, gastrointestinal tract, central nervous system, and an increased risk in developing breast and thyroid carcinomas. Over 80 germline mutations of the tumor suppressor gene PTEN, on chromosome 10q23, have been reported in more than 100 unrelated patients and families; however, questions regarding distribution of the mutations in populations from different geographic areas, and phenotypic expression are still unclear. In this study the results are reported of mutation analysis of PTEN in 13 families from Spain and one family of Brazilian origin with Cowden syndrome. PTEN germ line mutations were detected in nine of them (64%). Five mutations were located in exon 5, one in exon 6, two in exon 7, and one in exon 8. Four of the mutations were novel. In another case, an identical change had been previously reported as a somatic mutation in an endometrial carcinoma. In one family, the patient presented a de novo mutation, which was not detected in his parents. In five patients, the detection of the PTEN germline mutation confirmed their condition, even in the absence of sufficient criteria to make the clinical diagnosis of Cowden syndrome.
引用
收藏
页码:639 / 644
页数:6
相关论文
共 46 条
[1]  
ALBRECHT S, 1992, CANCER-AM CANCER SOC, V70, P869, DOI 10.1002/1097-0142(19920815)70:4<869::AID-CNCR2820700424>3.0.CO
[2]  
2-E
[3]  
BANNAYAN GA, 1971, ARCH PATHOL, V92, P1
[4]  
Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO
[5]  
2-0
[6]   DERMATOPATHOLOGY OF COWDENS SYNDROME [J].
BROWNSTEIN, MH ;
MEHREGAN, AH ;
BIKOWSKI, B ;
LUPULESCU, A ;
PATTERSON, JC .
BRITISH JOURNAL OF DERMATOLOGY, 1979, 100 (06) :667-673
[7]  
BUDOWLE B, 1991, AM J HUM GENET, V48, P137
[8]   PTEN mutations in endometrial carcinomas: A molecular and clinicopathologic analysis of 38 cases [J].
Bussaglia, E ;
del Rio, E ;
Matias-Guiu, X ;
Prat, J .
HUMAN PATHOLOGY, 2000, 31 (03) :312-317
[9]   Identification of PTEN mutations in five families with Bannayan-Zonana syndrome [J].
Çelebi, JT ;
Chen, FF ;
Zhang, H ;
Ping, XL ;
Tsou, HC ;
Peacocke, M .
EXPERIMENTAL DERMATOLOGY, 1999, 8 (02) :134-139
[10]  
Çelebi JT, 1999, J MED GENET, V36, P360